Almi Invest has made a significant investment in the company Epigenica early in the fall. The company is focused on advancing epigenomics by delivering state-of-the-art epigenetic screening tools. With its multiplexing technology, the company offers its customers more comprehensive information faster, at a fraction of the cost they currently pay for the same knowledge.